EUVIMEDEUVIMED entdecken
Crossref

Metabolomics profiling and chemoresistance mechanisms in ovarian cancer cell lines: Implications for targeting glutathione pathway

Pedro Alarcon-Zapata, Andy J Perez, Karin Toledo-Oñate, Hector Contreras, Valeska Ormazabal, Estefania Nova-Lamperti, Claudio A Aguayo, Carlos Salomon, Felipe A Zuniga

Life Sciences · 2023-11 · 333 · 122166

DOI: 10.1016/j.lfs.2023.122166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2023-11. Verfasst von Pedro Alarcon-Zapata und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepcion, Chile; Departamento de Ciencias Básicas, Facultad …. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Universidad de Concepción, Agencia Nacional de Investigación y Desarrollo, Fondo Nacional de Desarrollo Científico y Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer presents a significant challenge due to its high rate of chemoresistance, which complicates the effectiveness of drug-response therapy. This study provides a comprehensive metabolomic analysis of ovarian cancer cell lines OVCAR-3 and SK-OV-3, characterizing their distinct metabolic landscapes. Metabolomics coupled with chemometric analysis enabled us to discriminate between the metabolic profiles of these two cell lines. The OVCAR-3 cells, which are sensitive to doxorubicin (DOX), exhibited a preference for biosynthetic pathways associated with cell proliferation. Conversely, DOX-resistant SK-OV-3 cells favored fatty acid oxidation for energy maintenance. Notably, a marked difference in glutathione (GSH) metabolism was observed between these cell lines. Our investigations further revealed that GSH depletion led to a profound change in drug sensitivity, inducing a shift from a cytostatic to a cytotoxic response. The results derived from this comprehensive metabolomic analysis offer potential targets for novel therapeutic strategies to overcome drug resistance. Our study suggests that targeting the GSH pathway could potentially enhance chemotherapy's efficacy in treating ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsHumansFemaleDrug Resistance, NeoplasmApoptosisCell Line, TumorDoxorubicinGlutathione

Stichwörter der Autor:innen

ChemoresistanceGlutathioneMetabolomicsOvarian cancerSK-OV-3 cells

Substanzen

DoxorubicinGlutathione

Autor:innen und Institutionen

  • Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepcion, Chile; Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomás, Concepción, Chile.
  • Department of Instrumental Analysis, Faculty of Pharmacy, University of Concepcion, Chile.
  • Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepcion, Chile.
  • Department of Pharmacology, Faculty of Biological Sciences, University of Concepcion, Chile.
  • Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, Faculty of Medicine, University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, The University of Queensland,…
  • Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepcion, Chile. Electronic address: fzuniga@udec.cl.

Förderung

  • Universidad de Concepción
  • Agencia Nacional de Investigación y Desarrollo
  • Fondo Nacional de Desarrollo Científico y Tecnológico
  • National Health and Medical Research Council

Zitieren

APA

Alarcon-Zapata, P., Perez, A. J., Toledo-Oñate, K., Contreras, H., Ormazabal, V., Nova-Lamperti, E., Aguayo, C. A., Salomon, C., & Zuniga, F. A. (2023). Metabolomics profiling and chemoresistance mechanisms in ovarian cancer cell lines: Implications for targeting glutathione pathway. Life Sciences, 333, 122166. https://doi.org/10.1016/j.lfs.2023.122166

Vancouver

Alarcon-Zapata P, Perez AJ, Toledo-Oñate K, Contreras H, Ormazabal V, Nova-Lamperti E, et al. Metabolomics profiling and chemoresistance mechanisms in ovarian cancer cell lines: Implications for targeting glutathione pathway. Life Sciences. 2023;333:122166. doi:10.1016/j.lfs.2023.122166

BibTeX
@article{AlarconZapata2023,
  author = {Alarcon-Zapata, Pedro and Perez, Andy J and Toledo-Oñate, Karin and Contreras, Hector and Ormazabal, Valeska and Nova-Lamperti, Estefania and Aguayo, Claudio A and Salomon, Carlos and Zuniga, Felipe A},
  title = {Metabolomics profiling and chemoresistance mechanisms in ovarian cancer cell lines: Implications for targeting glutathione pathway},
  journal = {Life Sciences},
  year = {2023},
  volume = {333},
  pages = {122166},
  doi = {10.1016/j.lfs.2023.122166}
}
Kostenlos starten →